- Investopedia•4 hours ago
Pfizer is planning to exit the Brazilian market as it puts its generic drug joint venture stake up for sale. Teva and Mylan are possible bidders for the asset.
Teva Pharmaceuticals (TEVA) stock is rising in early morning trading today after the company won antitrust approval to purchase Allergan's (AGN) generics business.
Teva Pharmaceutical Industries LimitedNYSE
|Bid||53.70 x 900|
|Ask||53.71 x 2000|
|52wk Range||48.01 - 71.68|
|Day's Range||53.61 - 54.83|
|Avg Vol (3m)||6,217,103|
As of 2:32 PM EDT. NYSE Real Time Price. Market open.